Francesco Di Raimondo

Research interests

Publications

• Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30152-4

• Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

  Blood Reviews · 2019 · https://doi.org/10.1016/j.blre.2019.01.001

• Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32984-2

• The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

  Leukemia · 2015 · 10.1038/leu.2015.73

• Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.52.0023

• Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1402888

• Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.52.2466

• R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.45.0866

• Treatment of Older Patients with Mantle-Cell Lymphoma

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200920

• Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

  Blood · 2011 · https://doi.org/10.1182/blood-2011-07-365320

• AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

  Blood · 2011 · 10.1182/blood-2010-08-302950

• BRAF Mutations in Hairy-Cell Leukemia

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1014209

• Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

  Blood · 2011 · 10.1182/blood-2011-03-344333

• Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

  Blood · 2011 · 10.1182/blood-2011-04-347575

• Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

  The Lancet · 2010 · 10.1016/s0140-6736(10)61424-9

• Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

  Blood · 2010 · https://doi.org/10.1182/blood-2010-03-276196

• Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.20.6490

• Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.21.3991

• Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

  Blood · 2008 · 10.1182/blood-2007-10-116749

• Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

  Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.11.6525

• Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

  Blood · 2007 · 10.1182/blood-2006-10-052746

• Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study

  Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.10.2509

• Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.12.3463

• Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors

  The Journal of Experimental Medicine · 2004 · 10.1084/jem.20031175

• Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

  Blood · 2002 · https://doi.org/10.1182/blood.v99.3.863

Current projects

No projects listed.